1. Home
  2. AVDL vs LILA Comparison

AVDL vs LILA Comparison

Compare AVDL & LILA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • LILA
  • Stock Information
  • Founded
  • AVDL 2015
  • LILA 2017
  • Country
  • AVDL Ireland
  • LILA Bermuda
  • Employees
  • AVDL N/A
  • LILA N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • LILA Cable & Other Pay Television Services
  • Sector
  • AVDL Health Care
  • LILA Telecommunications
  • Exchange
  • AVDL Nasdaq
  • LILA Nasdaq
  • Market Cap
  • AVDL 1.5B
  • LILA 1.5B
  • IPO Year
  • AVDL 1996
  • LILA N/A
  • Fundamental
  • Price
  • AVDL $18.57
  • LILA $8.58
  • Analyst Decision
  • AVDL Buy
  • LILA Sell
  • Analyst Count
  • AVDL 10
  • LILA 1
  • Target Price
  • AVDL $18.94
  • LILA $6.50
  • AVG Volume (30 Days)
  • AVDL 4.4M
  • LILA 213.2K
  • Earning Date
  • AVDL 11-11-2025
  • LILA 11-05-2025
  • Dividend Yield
  • AVDL N/A
  • LILA N/A
  • EPS Growth
  • AVDL N/A
  • LILA N/A
  • EPS
  • AVDL N/A
  • LILA N/A
  • Revenue
  • AVDL $221,075,000.00
  • LILA $4,409,700,000.00
  • Revenue This Year
  • AVDL $64.21
  • LILA $1.35
  • Revenue Next Year
  • AVDL $30.80
  • LILA N/A
  • P/E Ratio
  • AVDL N/A
  • LILA N/A
  • Revenue Growth
  • AVDL 132.35
  • LILA N/A
  • 52 Week Low
  • AVDL $6.38
  • LILA $4.26
  • 52 Week High
  • AVDL $18.65
  • LILA $10.79
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 79.97
  • LILA 64.94
  • Support Level
  • AVDL $13.83
  • LILA $8.05
  • Resistance Level
  • AVDL $18.65
  • LILA $8.09
  • Average True Range (ATR)
  • AVDL 0.59
  • LILA 0.24
  • MACD
  • AVDL 0.43
  • LILA 0.04
  • Stochastic Oscillator
  • AVDL 97.93
  • LILA 93.53

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About LILA Liberty Latin America Ltd.

Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.

Share on Social Networks: